A Study of Nasopharyngeal Carcinoma From Guangdong

• Conditions: Nasopharyngeal Cancer

• Registration Number: NCT03003182
• Lead Sponsor: Sun Yat-sen University

Brief Summary

This prospective cohort study aims to establish prognostic models, to discover toxicity associated predictors and to validate randomized trials in clinical practice.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-12-18
• Study First Submitted QC: 2016-12-23
• Study First Posted: 2016-12-26
• Study Start: 2017-05-10
• Status Verified: 2017-06
• Last Update Submitted: 2017-06-13
• Last Update Posted: 2017-06-15
• Primary Completion: 2019-05
• Study Completion: 2021-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• histological confirmed nasopharyngeal carcinoma;
• scanned by magnetic resonance imaging from calvaria vertex to clavicles before treatment;
• pretreatment Epstein-Barr virus deoxyribonucleic acid copy number is available;
• irradiated with intensity-modulated radiotherapy;

Exclusion Criteria

• finishing anticancer therapy in two or more hospitals;
• pregnancy or lactation;
• diagnosed with other sort of cancer before or during the treatment.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
overall survival	3-years

Secondary Outcome Measures

Name	Time	Method
Number of participants with treatment-related acute adverse events as assessed by CTCAE v4.0	30-days

Trial Locations

Locations (1)

Sun Yat-sen University Cancer Center; 🇨🇳 Guangzhou, Guangdong, China